Saba Capital Management’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-94,264
Closed -$193K 355
2025
Q2
$193K Hold
94,264
﹤0.01% 216
2025
Q1
$107K Hold
94,264
﹤0.01% 161
2024
Q4
$29.1K Hold
94,264
﹤0.01% 212
2024
Q3
$30.8K Hold
94,264
﹤0.01% 236
2024
Q2
$43.4K Hold
94,264
﹤0.01% 248
2024
Q1
$149K Hold
94,264
﹤0.01% 205
2023
Q4
$192K Hold
94,264
﹤0.01% 272
2023
Q3
$132K Sell
94,264
-76,114
-45% -$78.8K ﹤0.01% 315
2023
Q2
$93.7K Sell
170,378
-4,135
-2% -$2.19K ﹤0.01% 372
2023
Q1
$118K Hold
174,513
﹤0.01% 459
2022
Q4
$288K Sell
174,513
-173,546
-50% -$487K ﹤0.01% 562
2022
Q3
$1.61M Sell
348,059
-19,233
-5% -$113K 0.02% 650
2022
Q2
$1.86M Sell
367,292
-32,708
-8% -$238K 0.02% 664
2022
Q1
$2.85M Hold
400,000
0.04% 532
2021
Q4
$3.73M Buy
400,000
+304,315
+318% +$2.71M 0.06% 431
2021
Q3
$949K Hold
95,685
0.02% 443
2021
Q2
$951K Buy
+95,685
New +$963K 0.03% 369
2021
Q1
Sell
-17,318
Closed -$187K 458
2020
Q4
$187K Sell
17,318
-80,443
-82% -$828K 0.01% 159
2020
Q3
$1.01M Buy
+97,761
New +$1.02M 0.04% 101

Other funds holding TOI

Saba Capital Management's TOI Position: Q3 2025 in Review

Saba Capital Management sold out of The Oncology Institute (TOI) in Q3 2025, closing a stake of 94,264 shares — an estimated $193K sold.

Saba Capital Management first reported a position in TOI in Q3 2020 and held it in 19 quarters. The position peaked at $3.73M in Q4 2021. 108 funds tracked by Wall St. Rank hold TOI as of Q3 2025.

  • Saba Capital Management reported no remaining The Oncology Institute position as of Q3 2025 after selling out during the quarter.
  • Saba Capital Management sold 94,264 The Oncology Institute shares in Q3 2025, an estimated $193K.
  • Saba Capital Management first reported a position in The Oncology Institute in Q3 2020 and held it in 19 quarters.
  • Saba Capital Management's The Oncology Institute position peaked at $3.73M in Q4 2021.
  • 108 funds tracked by Wall St. Rank held The Oncology Institute as of Q3 2025.

Based on Saba Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.